Alpenglow Biosciences
Alpenglow Biosciences is an end-to-end 3D pathology platform that aims to accelerate drug development and improve clinical diagnostics.
About Alpenglow Biosciences
Alpenglow Biosciences is an end-to-end 3D pathology platform. Lightspeed Microscopy reimagines pathology by providing a full-stack solution to nondestructively image large tissues in 3D at sub-cellular resolution. Its novel chemistry patented high-throughput light-sheet microscope, and cloud-based AI analysis software adds a new dimension to pathology.
Company Facts
- Headquarters
- Seattle
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Total Funding
- $7,850,000
- Last Funding Type
- undisclosed
- Last Funding Date
- 2026-01-08
- Website
- alpenglowbiosciences.com
Industries & Categories
3D Technology, Life Science, Medical
Social Links
Canonical: https://fsome.com/organization/alpenglow-biosciences-35077 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.